Advertisement
Screener

CAREDX, INC. (CDNA) Selling and Marketing Expense

2.8 / 5 stars · 68/120 Roast Me

CAREDX, INC. Selling and Marketing Expense

CAREDX, INC. (CDNA) reported Selling and Marketing Expense of $33.44 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:SellingAndMarketingExpense · last filed 2026-07-30

  • CAREDX, INC. selling and marketing expense for the quarter ending 2026-06-30 was $33.44M, a 37.74% increase year-over-year.
  • CAREDX, INC. selling and marketing expense for the quarter ending 2026-03-31 was $30.37M, a 32.11% increase year-over-year.
  • CAREDX, INC. selling and marketing expense for the quarter ending 2025-12-31 was $30.92M, a 44.90% increase year-over-year.
  • CAREDX, INC. selling and marketing expense for the quarter ending 2025-09-30 was $24.45M, a 23.47% increase year-over-year.
  • CAREDX, INC. selling and marketing expense for fiscal 2025 was $102.64M, a 25.21% increase from fiscal 2024.
  • CAREDX, INC. selling and marketing expense for fiscal 2024 was $81.97M, a 2.48% decline from fiscal 2023.
  • CAREDX, INC. selling and marketing expense for fiscal 2023 was $84.06M, a 12.46% decline from fiscal 2022.
  • CAREDX, INC. selling and marketing expense for fiscal 2022 was $96.03M, a 24.31% increase from fiscal 2021.
Period endSelling and Marketing Expense 3 monthSelling and Marketing Expense 6 monthSelling and Marketing Expense 9 monthSelling and Marketing Expense 12 monthSelling and Marketing Expense 12 month as first filed
2026-06-30$33.44M
10-Q · filed 2026-07-30
$63.81M
10-Q · filed 2026-07-30
$94.74M
derived: sum of 3 quarters · filed 2026-07-30
$119.19M
derived: sum of 4 quarters · filed 2026-07-30
2026-03-31$30.37M
10-Q · filed 2026-04-28
$61.30M
derived: sum of 2 quarters · filed 2026-04-28
$85.75M
derived: sum of 3 quarters · filed 2026-04-28
$110.03M
derived: sum of 4 quarters · filed 2026-07-30
2025-12-31$30.92M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25
$55.37M
derived: sum of 2 quarters · filed 2026-02-25
$79.65M
derived: sum of 3 quarters · filed 2026-07-30
$102.64M
10-K · filed 2026-02-25
2025-09-30$24.45M
10-Q · filed 2025-11-04
$48.73M
derived: sum of 2 quarters · filed 2026-07-30
$71.72M
10-Q · filed 2025-11-04
$93.06M
derived: sum of 4 quarters · filed 2026-07-30
2025-06-30$24.28M
10-Q · filed 2026-07-30
$47.27M
10-Q · filed 2026-07-30
$68.61M
derived: sum of 3 quarters · filed 2026-07-30
$88.41M
derived: sum of 4 quarters · filed 2026-07-30
2025-03-31$22.99M
10-Q · filed 2026-04-28
$44.33M
derived: sum of 2 quarters · filed 2026-04-28
$64.13M
derived: sum of 3 quarters · filed 2026-04-28
$85.14M
derived: sum of 4 quarters · filed 2026-04-28
2024-12-31$21.34M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25
$41.14M
derived: sum of 2 quarters · filed 2026-02-25
$62.15M
derived: sum of 3 quarters · filed 2026-02-25
$81.97M
10-K · filed 2026-02-25
$81.72M
10-K · filed 2025-02-28
2024-09-30$19.80M
10-Q · filed 2025-11-04
$40.80M
derived: sum of 2 quarters · filed 2025-11-04
$60.63M
10-Q · filed 2025-11-04
$81.36M
derived: sum of 4 quarters · filed 2026-02-25
2024-06-30$21.00M
10-Q · filed 2025-08-06
$40.83M
10-Q · filed 2025-08-06
$61.56M
derived: sum of 3 quarters · filed 2026-02-25
$80.03M
derived: sum of 4 quarters · filed 2026-02-25
2024-03-31$19.83M
10-Q · filed 2025-04-30
$40.56M
derived: sum of 2 quarters · filed 2026-02-25
$59.03M
derived: sum of 3 quarters · filed 2026-02-25
$80.66M
derived: sum of 4 quarters · filed 2026-02-25
2023-12-31$20.73M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25
$39.20M
derived: sum of 2 quarters · filed 2026-02-25
$60.83M
derived: sum of 3 quarters · filed 2026-02-25
$84.06M
10-K · filed 2026-02-25
$83.33M
10-K · filed 2024-02-28
2023-09-30$18.47M
10-Q · filed 2024-11-04
$40.10M
derived: sum of 2 quarters · filed 2024-11-04
$63.34M
10-Q · filed 2024-11-04
$87.00M
derived: sum of 4 quarters · filed 2025-02-28
2023-06-30$21.63M
10-Q · filed 2024-07-31
$44.86M
10-Q · filed 2024-07-31
$68.53M
derived: sum of 3 quarters · filed 2025-02-28
$90.79M
derived: sum of 4 quarters · filed 2025-02-28
2023-03-31$23.23M
10-Q · filed 2024-05-09
$46.90M
derived: sum of 2 quarters · filed 2025-02-28
$69.16M
derived: sum of 3 quarters · filed 2025-02-28
$96.11M
derived: sum of 4 quarters · filed 2025-02-28
2022-12-31$23.67M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28
$45.93M
derived: sum of 2 quarters · filed 2025-02-28
$72.88M
derived: sum of 3 quarters · filed 2025-02-28
$96.03M
10-K · filed 2025-02-28
2022-09-30$22.26M
10-Q · filed 2023-11-08
$49.21M
derived: sum of 2 quarters · filed 2023-11-08
$72.36M
10-Q · filed 2023-11-08
$93.18M
derived: sum of 4 quarters · filed 2024-02-28
2022-06-30$26.95M
10-Q · filed 2023-08-08
$50.10M
10-Q · filed 2023-08-08
$70.92M
derived: sum of 3 quarters · filed 2024-02-28
$92.29M
derived: sum of 4 quarters · filed 2024-02-28
2022-03-31$23.15M
10-Q · filed 2023-05-10
$43.97M
derived: sum of 2 quarters · filed 2024-02-28
$65.34M
derived: sum of 3 quarters · filed 2024-02-28
$84.94M
derived: sum of 4 quarters · filed 2024-02-28
2021-12-31$20.82M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28
$42.19M
derived: sum of 2 quarters · filed 2024-02-28
$61.79M
derived: sum of 3 quarters · filed 2024-02-28
$77.25M
10-K · filed 2024-02-28
2021-09-30$21.37M
10-Q · filed 2022-11-03
$40.97M
derived: sum of 2 quarters · filed 2022-11-03
$56.42M
10-Q · filed 2022-11-03
$72.55M
derived: sum of 4 quarters · filed 2023-02-27
2021-06-30$19.60M
10-Q · filed 2022-08-04
$35.05M
10-Q · filed 2022-08-04
$51.18M
derived: sum of 3 quarters · filed 2023-02-27
$65.05M
derived: sum of 4 quarters · filed 2023-02-27
2021-03-31$15.45M
10-Q · filed 2022-05-05
$31.58M
derived: sum of 2 quarters · filed 2023-02-27
$45.45M
derived: sum of 3 quarters · filed 2023-02-27
$57.59M
derived: sum of 4 quarters · filed 2023-02-27
2020-12-31$16.13M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27
$30.00M
derived: sum of 2 quarters · filed 2023-02-27
$42.13M
derived: sum of 3 quarters · filed 2023-02-27
$53.86M
10-K · filed 2023-02-27
2020-09-30$13.87M
10-Q · filed 2021-10-28
$26.00M
derived: sum of 2 quarters · filed 2021-10-28
$37.73M
10-Q · filed 2021-10-28
$47.99M
derived: sum of 4 quarters · filed 2022-02-24
2020-06-30$12.13M
10-Q · filed 2021-07-29
$23.86M
10-Q · filed 2021-07-29
$34.12M
derived: sum of 3 quarters · filed 2022-02-24
$45.18M
derived: sum of 4 quarters · filed 2022-02-24
2020-03-31$11.72M
10-Q · filed 2021-05-05
$21.99M
derived: sum of 2 quarters · filed 2022-02-24
$33.05M
derived: sum of 3 quarters · filed 2022-02-24
$43.69M
derived: sum of 4 quarters · filed 2022-02-24
2019-12-31$10.27M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24
$21.32M
derived: sum of 2 quarters · filed 2022-02-24
$31.97M
derived: sum of 3 quarters · filed 2022-02-24
$38.89M
10-K · filed 2022-02-24
2019-09-30$11.06M
10-Q · filed 2020-10-29
$21.70M
derived: sum of 2 quarters · filed 2020-10-29
$28.63M
10-Q · filed 2020-10-29
$34.38M
derived: sum of 4 quarters · filed 2021-02-24
2019-06-30$10.64M
10-Q · filed 2020-08-04
$17.57M
10-Q · filed 2020-08-04
$23.32M
derived: sum of 3 quarters · filed 2021-02-24
$29.29M
derived: sum of 4 quarters · filed 2021-02-24
2019-03-31$6.92M
10-Q · filed 2020-04-30
$12.68M
derived: sum of 2 quarters · filed 2021-02-24
$18.65M
derived: sum of 3 quarters · filed 2021-02-24
$24.51M
derived: sum of 4 quarters · filed 2021-02-24
2018-12-31$5.75M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24
$11.72M
derived: sum of 2 quarters · filed 2021-02-24
$17.59M
derived: sum of 3 quarters · filed 2021-02-24
$21.67M
10-K · filed 2021-02-24
2018-09-30$5.97M
10-Q · filed 2019-10-31
$11.83M
derived: sum of 2 quarters · filed 2019-10-31
$15.92M
10-Q · filed 2019-10-31
$18.98M
derived: sum of 4 quarters · filed 2020-02-28
2018-06-30$5.86M
10-Q · filed 2019-08-01
$9.95M
10-Q · filed 2019-08-01
$13.01M
derived: sum of 3 quarters · filed 2020-02-28
$16.26M
derived: sum of 4 quarters · filed 2020-02-28
2018-03-31$4.08M
10-Q · filed 2019-05-08
$7.15M
derived: sum of 2 quarters · filed 2020-02-28
$10.40M
derived: sum of 3 quarters · filed 2020-02-28
$13.67M
derived: sum of 4 quarters · filed 2020-02-28
2017-12-31$3.06M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28
$6.32M
derived: sum of 2 quarters · filed 2020-02-28
$9.59M
derived: sum of 3 quarters · filed 2020-02-28
$12.81M
10-K · filed 2020-02-28
2017-09-30$3.25M
10-Q · filed 2018-11-08
$6.53M
derived: sum of 2 quarters · filed 2018-11-08
$9.75M
10-Q · filed 2018-11-08
$12.37M
derived: sum of 4 quarters · filed 2019-03-06
2017-06-30$3.27M
10-Q · filed 2018-08-09
$6.49M
10-Q · filed 2018-08-09
$9.11M
derived: sum of 3 quarters · filed 2019-03-06
$12.56M
derived: sum of 4 quarters · filed 2019-03-06
2017-03-31$3.22M
10-Q · filed 2018-05-10
$5.84M
derived: sum of 2 quarters · filed 2019-03-06
$9.29M
derived: sum of 3 quarters · filed 2019-03-06
$12.65M
derived: sum of 4 quarters · filed 2019-03-06
2016-12-31$2.62M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06
$6.07M
derived: sum of 2 quarters · filed 2019-03-06
$9.43M
derived: sum of 3 quarters · filed 2019-03-06
$11.17M
10-K · filed 2019-03-06
2016-09-30$3.45M
10-Q · filed 2017-11-09
$6.81M
derived: sum of 2 quarters · filed 2017-11-09
$8.54M
10-Q · filed 2017-11-09
$10.44M
derived: sum of 4 quarters · filed 2018-03-22
2016-06-30$3.36M
10-Q · filed 2017-08-11
$5.09M
10-Q · filed 2017-08-11
$6.99M
derived: sum of 3 quarters · filed 2018-03-22
$9.05M
derived: sum of 4 quarters · filed 2018-03-22
2016-03-31$1.74M
10-Q · filed 2017-06-09
$3.63M
derived: sum of 2 quarters · filed 2018-03-22
$5.70M
derived: sum of 3 quarters · filed 2018-03-22
$8.22M
derived: sum of 4 quarters · filed 2018-03-22
2015-12-31$1.90M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-22
$3.96M
derived: sum of 2 quarters · filed 2018-03-22
$6.48M
derived: sum of 3 quarters · filed 2018-03-22
$8.35M
10-K · filed 2018-03-22
2015-09-30$2.06M
10-Q · filed 2016-11-14
$4.59M
derived: sum of 2 quarters · filed 2016-11-14
$6.45M
10-Q · filed 2016-11-14
$8.25M
derived: sum of 4 quarters · filed 2017-04-21
2015-06-30$2.53M
10-Q · filed 2016-08-22
$4.55M
10-Q · filed 2016-08-22
$6.18M
derived: sum of 3 quarters · filed 2017-04-21
$7.94M
derived: sum of 4 quarters · filed 2017-04-21
2015-03-31$2.02M
10-Q · filed 2016-05-16
$3.66M
derived: sum of 2 quarters · filed 2017-04-21
$5.41M
derived: sum of 3 quarters · filed 2017-04-21
$7.02M
derived: sum of 4 quarters · filed 2017-04-21
2014-12-31$1.64M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-04-21
$3.39M
derived: sum of 2 quarters · filed 2017-04-21
$5.00M
derived: sum of 3 quarters · filed 2017-04-21
$6.47M
10-K · filed 2017-04-21
2014-09-30$1.75M
10-Q · filed 2015-11-13
$3.36M
derived: sum of 2 quarters · filed 2015-11-13
$4.84M
10-Q · filed 2015-11-13
$6.16M
derived: sum of 4 quarters · filed 2016-03-29
2014-06-30$1.61M
10-Q · filed 2015-08-12
$3.08M
10-Q · filed 2015-08-12
$4.41M
derived: sum of 3 quarters · filed 2016-03-29
$5.86M
derived: sum of 4 quarters · filed 2016-03-29
2014-03-31$1.47M
10-Q · filed 2015-05-14
$2.80M
derived: sum of 2 quarters · filed 2016-03-29
$4.25M
derived: sum of 3 quarters · filed 2016-03-29
$5.80M
derived: sum of 4 quarters · filed 2016-03-29
2013-12-31$1.32M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-29
$2.77M
derived: sum of 2 quarters · filed 2016-03-29
$4.32M
derived: sum of 3 quarters · filed 2016-03-29
$5.89M
10-K · filed 2016-03-29
2013-09-30$1.45M
10-Q · filed 2014-11-14
$3.00M
derived: sum of 2 quarters · filed 2014-11-14
$4.57M
10-Q · filed 2014-11-14
2013-06-30$1.55M
10-Q · filed 2014-08-28
$3.12M
10-Q · filed 2014-08-28
2012-12-31$5.42M
10-K · filed 2015-03-31

Similar stocks

Stock NameCountryMarket CapPE Ratio
Celcuity Inc. (CELC)United States$3.887B-22.62
VERACYTE, INC. (VCYT)United States$3.904B41.21
Fortrea Holdings Inc. (FTRE)United States$1.903B-19.43
Personalis, Inc. (PSNL)United States$1.769B-13.30
CASTLE BIOSCIENCES INC (CSTL)United States$1.074B-37.45
Lumexa Imaging Holdings, Inc. (LMRI)United States$0.951B
GRAIL, Inc. (GRAL)United States$5.591B-7.78
RadNet, Inc. (RDNT)United States$5.611B-229.65
Fulgent Genetics, Inc. (FLGT)United States$0.593B-6.70
BIODESIX INC (BDSX)United States$0.312B